NUTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important Deadline in Securities Class Action - NUTX

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nutex Health Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Nutex securities between August 8, 2024, and August 14, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 21, 2025 [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. Group 3: Case Allegations - The lawsuit alleges that Nutex made false and misleading statements regarding its financial practices, including the engagement with HaloMD, which was accused of defrauding insurance companies [5]. - It is claimed that Nutex overstated its ability to remediate internal control weaknesses and improperly classified stock-based compensation obligations, leading to an increased risk of failing to file timely financial reports with the SEC [5].